CSF2 and breast cancer: Concordantly, it was shown that in the murine model of BC, GM-CSF inhibited tumor progression and metastasis through their effects on monocytes and the secretion of soluble VEGFR-1, which in turn inactivates the VEGF and blocks angiogenesis [121].